A Look at ANI Pharmaceuticals Inc (ANIP) After 3.7% Decline -- GF Value $100.29 vs Price $70.84

gurufocus.com · 2026-10-13

On October 13, 2026, ANI Pharmaceuticals Inc (ANIP) shares fell 3.7% to $70.84, which puts the stock near its 52-week low of $69.58. Over the past year, ANIP ha

TickrTrends take: ANI Pharmaceuticals Inc operates in the Healthcare sector, and according to TickrTrends analysis, the stock is currently considered undervalued. The recent market decline has widened the gap between the GF Value estimate and the current trading price, which may be relevant for investors focused on valuation metrics. Observers of the stock should monitor whether this valuation gap reflects temporary market pressure or signals a sustained repricing of the company's fundamental value.

Read the full story at gurufocus.com →